Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Cytofluorometric assessment of cell cycle progression in irradiated cells
Carlos Jiménez-Cortegana
,
Vanessa Klapp
, Norma Bloy
, Claudia Galassi
, Ai Sato
, Takahiro Yamazaki
, Aitziber Buqué
, Lorenzo Galluzzi
*
, Giulia Petroni
*
Corresponding author for this work
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cytofluorometric assessment of cell cycle progression in irradiated cells'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cell Cycle Progression
100%
Radiation Therapy
100%
Cytotoxic Effect
33%
Cytostatic Effect
33%
Malignant Cells
16%
Immune Response
16%
Estrogen Receptor
16%
Breast Cancer
16%
DNA Repair
16%
Ionizing Radiation
16%
MCF-7 Cells
16%
Anticancer Activity
16%
Flow Cytometry
16%
Cancer Control
16%
DNA Replication
16%
Radiosensitivity
16%
Cancer Cell Lines
16%
Tumor Targeting
16%
Integral Component
16%
Macromolecules
16%
Therapeutic Modalities
16%
Neoplastic Cells
16%
Therapeutic Window
16%
Radiation Effects
16%
Cell Cycle Distribution
16%
Simple Flow
16%
Rate Capacity
16%
Limited Capacity
16%
In Vitro Tumor Models
16%
Minimal Variation
16%
Central Approach
16%
Immunology and Microbiology
Cytotoxicity
100%
Cell Cycle Progression
100%
Radioresistance
50%
Cancer Cell Line
50%
Immune Response
50%
Antineoplastic Activity
50%
Cell Cycle
50%
DNA Repair
50%
Macromolecule
50%
DNA Synthesis
50%
Medicine and Dentistry
Cell Cycle Progression
100%
Radiation Therapy
100%
Cytotoxicity
33%
Cytostatic
33%
Immune Response
16%
Neoplasm
16%
Tumor Model
16%
Breast Cancer
16%
Cell Cycle
16%
DNA Repair
16%
Ionizing Radiation
16%
Flow Cytometry
16%
Cancer Cell Line
16%
Antineoplastic Activity
16%
Cancer Control
16%
Estrogen Receptor
16%
Radiosensitivity
16%
Therapeutic Window
16%
DNA Synthesis
16%